GLP-1 drugs could save Uncle Sam billions — Congress should account for that
PositiveU.S News

The rising prevalence of obesity in the U.S. is not just a health issue; it's a significant economic burden, costing the healthcare system around $173 billion each year. As Congress considers budget allocations, it's crucial for the Congressional Budget Office to refine its methods to include the long-term economic impacts of obesity and the potential savings from effective treatments like GLP-1 drugs. By addressing this, lawmakers can make informed decisions that could ultimately save billions and improve public health.
— Curated by the World Pulse Now AI Editorial System